Cardiovascular Diseases Research in Delaware
Cardiovascular Diseases Research (93.837) awarded $27.7 million to recipients in Delaware in 24 grants from fiscal 2021 to 2025, 0.2% of the program's national total. University of Delaware received the most, $10.8 million.
- Awarded in Delaware$27.7 million
- Awards24
- Share of the program0.2%
- Rank among states37th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $3.8 million |
| FY 2022 | 9 | $3.1 million |
| FY 2023 | 12 | $5.5 million |
| FY 2024 | 12 | $6.5 million |
| FY 2025 | 10 | $8.8 million |
Recipients in Delaware
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Delaware | Colleges and universities | 14 | $10.8 million |
| The Nemours Foundation | Nonprofits | 4 | $6.5 million |
| Youngheartvalve, Inc. | Small businesses | 2 | $3.3 million |
| Inovodel, Inc. | Small businesses | 1 | $2.9 million |
| Velakor Biotherapeutics, Inc. | Small businesses | 1 | $2.1 million |
| Vasarya Therapeutics, Inc. | Small businesses | 1 | $1.5 million |
| Spheric Bio Inc | Small businesses | 1 | $598,636 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Delaware?
$27.7 million from fiscal 2021 to 2025, across 24 awards. Delaware ranks 37th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Delaware?
The largest recipient is University of Delaware, with $10.8 million in 14 awards. Next are The Nemours Foundation and Youngheartvalve, Inc..
Can organizations in Delaware apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Delaware
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Clean Energy Demonstrations
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies
- Drinking Water State Revolving Fund
- 1332 State Innovation Waivers
- Special Education Grants to States